Share on LinkedInShare on LinkedIn

ARTICLE · 15 AUGUST 2012

Inequitable Conduct Claims One Year After Therasense

Frederick Frei and Sean Wooden analyse case law around inequitable conduct one year after the landmark decision in Therasense v Becton Dickinson, and find that the defence remains viable.

United StatesIntellectual Property

Frederick Frei and Sean Wooden analyse case law around inequitable conduct one year after the landmark decision in Therasense v Becton Dickinson, and find that the defence remains viable.

ONE-MINUTE READ

The May 25 2011 Federal Circuit en banc decision in Therasense v Becton, Dickinson and Co made it harder to prove inequitable conduct in US patent cases, and was expected to do away with such allegations altogether. The America Invents Act further complicates the issue, as it mandates supplemental examination proceedings, which provide additional government assurances that a patent is valid and secured legitimately, presumably making the inequitable conduct defence even more of a dead letter. But one year after the ruling, case law has proven that inequitable conduct remains a viable defence to patent infringement, and will for some time.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from